| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/24/2012 | US20120128679 Human Antibodies to the Glucagon Receptor |
| 05/24/2012 | US20120128678 Diagnosis and treatment of cancer using anti-tmprss11e antibody |
| 05/24/2012 | US20120128677 Pancreatic cancer targets and uses thereof |
| 05/24/2012 | US20120128676 Muc1 antibodies |
| 05/24/2012 | US20120128671 Neutralizing molecules to influenza viruses |
| 05/24/2012 | US20120128669 Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections |
| 05/24/2012 | US20120128665 Preselection of subjects for therapeutic treatment based on hypoxic status |
| 05/24/2012 | US20120128664 Glycosylated antibodies |
| 05/24/2012 | US20120128663 Fc VARIANTS THAT EXTEND ANTIBODY HALF-LIFE |
| 05/24/2012 | US20120128658 Rage g82s-related methods and compositions for treating inflammatory disorders |
| 05/24/2012 | US20120128627 Il-17 homologous polypeptides and therapeutic uses thereof |
| 05/24/2012 | US20120128591 Anti-fap antibodies and methods of use |
| 05/24/2012 | US20120128586 Method for treating chronic lymphocytic leukemia |
| 05/24/2012 | US20120128584 Anti-cdh3 antibodies labeled with radioisotope label and uses thereof |
| 05/24/2012 | DE102011055265A1 Automatenfähiger Immunoassay für biogene Amine Machine-capable immunoassay for biogenic amines |
| 05/24/2012 | CA2818561A1 Regimens for treatments using anti-igf antibodies |
| 05/24/2012 | CA2818548A1 Neutralizing anti-ccl20 antibodies |
| 05/24/2012 | CA2818463A1 Luteinizing-hormone ligand and ligand-gonadotrophin complex |
| 05/24/2012 | CA2817964A1 Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii |
| 05/24/2012 | CA2817933A1 New ethiological agent |
| 05/24/2012 | CA2817751A1 Methods for producing recombinant proteins |
| 05/24/2012 | CA2816558A1 A collection and methods for its use |
| 05/24/2012 | CA2815921A1 Silent fc variants of anti-cd40 antibodies |
| 05/23/2012 | EP2455404A2 Anti-C5AR antibodies with improved properties |
| 05/23/2012 | EP2455403A1 Homogeneous humanized antibodies against JAM-A that inhibit proliferation |
| 05/23/2012 | EP2455402A1 Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof |
| 05/23/2012 | EP2455401A1 Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof |
| 05/23/2012 | EP2455400A1 Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof |
| 05/23/2012 | EP2455399A2 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof |
| 05/23/2012 | EP2455398A2 Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof |
| 05/23/2012 | EP2455395A1 MCM6 monoclonal antibodies and methods for their use in the detection of cervical disease |
| 05/23/2012 | EP2455102A1 Cancer therapeutic agent comprising antibody against cancer-specific membrane antigen |
| 05/23/2012 | EP2455100A2 Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof |
| 05/23/2012 | EP2454599A1 INHIBITORS OF THE NITRATION OF AMYLOID ß PEPTIDES AND THEIR USES IN THE DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE |
| 05/23/2012 | EP2454376A2 Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts |
| 05/23/2012 | EP2454285A2 Improved anti-serum albumin binding single variable domains |
| 05/23/2012 | EP2454284A2 Gram-positive bacteria specific binding compounds |
| 05/23/2012 | EP2454283A1 Means and methods for producing high affinity antibodies |
| 05/23/2012 | EP2454260A1 Immunodetection and quantification of pyrazolopyrimidine sedatives |
| 05/23/2012 | EP2453920A2 Antagonists, uses & methods for partially inhibiting tnfr1 |
| 05/23/2012 | EP2453919A1 Antibodies directed to gpnmb and uses thereof |
| 05/23/2012 | EP2453918A2 Rsv f protein compositions and methods for making same |
| 05/23/2012 | EP2453874A2 Methods for inhibiting yellow color and peroxide formation in a composition |
| 05/23/2012 | EP2225273B1 Stability testing of antibodies |
| 05/23/2012 | EP1963482B1 Avirulent isolate of neospora caninum and its uses |
| 05/23/2012 | EP1757698B1 Polypeptides having dna polymerase activity |
| 05/23/2012 | EP1709076B1 Method for the humanization of antibodies and humanized antibodies thereby obtained |
| 05/23/2012 | EP1678210B1 Anti-nik antibodies and uses thereof |
| 05/23/2012 | EP1601374B2 Compositions and methods for diagnosing and treating an inflammation |
| 05/23/2012 | CN1898267B Modified anti-cd52 antibody |
| 05/23/2012 | CN1867583B Optimized Fc variants and methods for their generation |
| 05/23/2012 | CN1849389B Methods for producing recombinant proteins |
| 05/23/2012 | CN1826138B Rg1 antibodies and uses thereof |
| 05/23/2012 | CN102471770A Antigen peptide and use thereof |
| 05/23/2012 | CN102471765A Neurotoxins exhibiting shortened biological activity |
| 05/23/2012 | CN102471383A β细胞标记抗体 β cell marker antibodies |
| 05/23/2012 | CN102471382A Tlr3 结合剂 Tlr3 binding agent |
| 05/23/2012 | CN102471381A 自身免疫性脱髓鞘疾病的诊断和治疗 Self-diagnosis and treatment of demyelinating autoimmune diseases |
| 05/23/2012 | CN102471380A Anti-fcrh5 antibodies and immunoconjugates and methods of use |
| 05/23/2012 | CN102471379A 作为诊断方法的igfbp-4片段检测 As a diagnostic method for detecting igfbp-4 fragment |
| 05/23/2012 | CN102471378A Readily isolated bispecific antibodies with native immuneoglobulin format |
| 05/23/2012 | CN102471377A 优化抗体的生产 Optimization of the production of antibodies |
| 05/23/2012 | CN102471376A Enzymatic antibody processing |
| 05/23/2012 | CN102471375A Stabilized immunoglobulin constant domains |
| 05/23/2012 | CN102470172A Combination therapy of an afucosylated CD20 antibody with fludarabine and/or mitoxantrone |
| 05/23/2012 | CN102470171A A complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent |
| 05/23/2012 | CN102470169A Autoantibody production inhibitor |
| 05/23/2012 | CN102465116A 一种猪圆环病毒2型的乳胶凝集检测方法及应用 A latex agglutination detection method and application of porcine circovirus type 2 |
| 05/23/2012 | CN102464726A 淫羊藿多糖及其组分和它们用于疫苗佐剂的用途 Epimedium polysaccharide and its components and their use for vaccine adjuvants |
| 05/23/2012 | CN102464720A 抗血管抑素受体人鼠嵌合单克隆抗体制备及其应用 Anti-angiostatin receptor chimeric monoclonal antibody and its application |
| 05/23/2012 | CN102464719A 鼠抗克伦特罗单克隆抗体及其用途 Mouse monoclonal antibodies anti-clenbuterol and its use |
| 05/23/2012 | CN102464718A 人源化之单克隆抗体、其氨基酸序列与核苷酸序列与其用途 Humanized monoclonal antibodies, amino acid sequence and the nucleotide sequence of its use |
| 05/23/2012 | CN102464717A 一种人源性抗核抗体的制备方法 A human-derived anti-nuclear antibody preparation |
| 05/23/2012 | CN102464716A 一种用于猪、人和蚊子中乙型脑炎病毒抗原检测的elisa试剂盒及应用 For pigs, humans and mosquitoes of Japanese encephalitis virus antigen detection kit and application elisa |
| 05/23/2012 | CN102464707A eEF-1α作为一种新的水稻内参蛋白质及其抗体的应用 eEF-1α as an internal reference of rice proteins and their antibodies to apply the new |
| 05/23/2012 | CN102464706A 一种新的水稻内参蛋白质及其单克隆抗体的应用 A new rice proteins and monoclonal antibodies internal control application |
| 05/23/2012 | CN102462842A Total \ polysaccharide of isatis root, ingredients of total polysaccharide, and use of total polysaccharide and ingredients of total polysaccharide as vaccine adjuvants |
| 05/23/2012 | CN102229658B Anti-rheumatoid arthritis polypeptide and its application in pharmacy |
| 05/23/2012 | CN102229657B Polypeptide against rheumatoid arthritis and application thereof in pharmacy |
| 05/23/2012 | CN102229656B Polypeptide against rheumatoid arthritis and application thereof in pharmacy |
| 05/23/2012 | CN102229655B Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy |
| 05/23/2012 | CN102229654B Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy |
| 05/23/2012 | CN102229653B Polypeptide resistant to rheumatoid arthritis and application of polypeptide in pharmacy |
| 05/23/2012 | CN102229652B Polypeptide against rheumatoid arthritis and application thereof in pharmacy |
| 05/23/2012 | CN102071205B Specific antigen of clonorchis sinensis and application thereof |
| 05/23/2012 | CN102031263B Method for preparing human DNA polymerase delta by using bombyx mori bioreactor |
| 05/23/2012 | CN101948539B IL-18 binding proteins |
| 05/23/2012 | CN101921731B Monoclonal antibody of fluoroquinolone medicines as well as preparation method and application thereof |
| 05/23/2012 | CN101892239B Schistosoma japonicum katsurada Frizzled 9 gene, protein and use |
| 05/23/2012 | CN101798577B Jatropha curcas phytoene synthetase gene sequence and application thereof in plants |
| 05/23/2012 | CN101724605B Foot-and-mouth disease virus (FMDV) resistant monoclonal antibody and identified epitope and application thereof |
| 05/23/2012 | CN101679485B Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof |
| 05/23/2012 | CN101575376B Anti-human rBPI23 monoclonal antibody and applications thereof |
| 05/23/2012 | CN101560255B Anti-rabies virus monoclonal antibody and application |
| 05/23/2012 | CN101475942B B19 virus VP1 unique region gene |
| 05/23/2012 | CN101235083B HIV-I resisting polypeptide, coded sequence and use thereof |
| 05/22/2012 | US8184000 Personal radio location system |
| 05/22/2012 | US8183354 Virus coat protein/receptor chimeras and methods of use |
| 05/22/2012 | US8183352 Attenuated vif DNA immunization cassettes for genetic vaccines |
| 05/22/2012 | US8183349 Markers of XMRV infection and uses thereof |